Patents by Inventor Stephen N. Mueller

Stephen N. Mueller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oncolytic virus therapy
    Patent number: 8137663
    Abstract: A method of treating a human subject with cancer is disclosed. A pharmaceutical composition is administered to the subject, the pharmaceutical composition comprising human leukocytes and a replication-competent oncolytic virus in suspension in a physiologically acceptable solution. Alternatively the pharmaceutical composition comprises human leukocytes or platelets infected with an oncolytic virus.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: March 20, 2012
    Assignee: Wellstat Biologics Corporation
    Inventors: William S. Groene, Jeffrey A. Miller, Stephen N. Mueller
  • Oncolytic virus therapy
    Patent number: 7595042
    Abstract: A method of treating a human subject with cancer is disclosed. A pharmaceutical composition is administered to the subject, the pharmaceutical composition comprising human leukocytes and a replication-competent oncolytic virus in suspension in a physiologically acceptable solution. Alternatively the pharmaceutical composition comprises human leukocytes or platelets infected with an oncolytic virus.
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: September 29, 2009
    Assignee: Wellstat Biologics Corporation
    Inventors: William S. Groene, Jeffrey A. Miller, Stephen N. Mueller
  • ONCOLYTIC VIRUS THERAPY
    Publication number: 20090180994
    Abstract: A method of treating a human subject with cancer is disclosed. A pharmaceutical composition is administered to the subject, the pharmaceutical composition comprising human leukocytes and a replication-competent oncolytic virus in suspension in a physiologically acceptable solution. Alternatively the pharmaceutical composition comprises human leukocytes or platelets infected with an oncolytic virus.
    Type: Application
    Filed: March 26, 2009
    Publication date: July 16, 2009
    Applicant: WELLSTAT BIOLOGICS CORPORATION
    Inventors: William S. Groene, Jeffrey A. Miller, Stephen N. Mueller
  • Oncolytic virus therapy
    Patent number: 7122182
    Abstract: A method of treating a human subject with cancer is disclosed. A pharmaceutical composition is administered to the subject, the pharmaceutical composition comprising human leukocytes and a replication-competent oncolytic virus in suspension in a physiologically acceptable solution. Alternatively the pharmaceutical composition comprises human leukocytes or platelets infected with an oncolytic virus.
    Type: Grant
    Filed: May 9, 2002
    Date of Patent: October 17, 2006
    Assignee: Wellstat Biologics Corporation
    Inventors: William S. Groene, Jeffrey A. Miller, Stephen N. Mueller
  • Oncolytic virus therapy
    Publication number: 20030077819
    Abstract: A method of treating a human subject with cancer is disclosed. A pharmaceutical composition is administered to the subject, the pharmaceutical composition comprising human leukocytes and a replication-competent oncolytic virus in suspension in a physiologically acceptable solution. Alternatively the pharmaceutical composition comprises human leukocytes or platelets infected with an oncolytic virus.
    Type: Application
    Filed: May 9, 2002
    Publication date: April 24, 2003
    Inventors: William S. Groene, Jeffrey A. Miller, Stephen N. Mueller